SG11202006669RA - Peptides and uses thereof - Google Patents

Peptides and uses thereof

Info

Publication number: SG11202006669RA
Authority: SG; Singapore
Prior art keywords: peptides
Prior art date: 2018-01-15

Application number

SG11202006669RA

Inventor

Andrew Gearing

David Kenley

Original Assignee

Lateral IP Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-01-15

Filing date

2019-01-15

Publication date

2020-08-28

2018-01-15 Priority claimed from AU2018900117A external-priority patent/AU2018900117A0/en

2019-01-15 Application filed by Lateral IP Pty Ltd filed Critical Lateral IP Pty Ltd

2020-08-28 Publication of SG11202006669RA publication Critical patent/SG11202006669RA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Zoology (AREA)
Neurology (AREA)
Toxicology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

SG11202006669RA 2018-01-15 2019-01-15 Peptides and uses thereof SG11202006669RA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU2018900117A AU2018900117A0 (en)		2018-01-15	Peptides and uses thereof
PCT/AU2019/050020 WO2019136528A1 (en)	2018-01-15	2019-01-15	Peptides and uses thereof

Publications (1)

Publication Number	Publication Date
SG11202006669RA true SG11202006669RA (en)	2020-08-28

Family

ID=67218208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11202006669RA SG11202006669RA (en)	2018-01-15	2019-01-15	Peptides and uses thereof

Country Status (11)

Country	Link
US (1)	US20200390850A1 (en)
EP (1)	EP3740228A4 (en)
JP (1)	JP7282099B2 (en)
KR (1)	KR20200130681A (en)
CN (1)	CN112218650A (en)
AU (1)	AU2019207531B2 (en)
BR (1)	BR112020014330A2 (en)
CA (1)	CA3088014A1 (en)
RU (1)	RU2020123165A (en)
SG (1)	SG11202006669RA (en)
WO (1)	WO2019136528A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2020237322A1 (en) *	2019-05-31	2020-12-03	Lateral IP Pty Ltd	Peptides and uses thereof
WO2021072392A1 (en) *	2019-10-10	2021-04-15	The Research Foundation For The State University Of New York	Analgesic and anesthetic peptides and other agents
WO2021127752A1 (en) *	2019-12-27	2021-07-01	Lateral IP Pty Ltd	Cyclic peptide receptor lanthionine synthetase c-like protein (lancl) and uses thereof
WO2021184062A1 (en) *	2020-03-16	2021-09-23	Lateral IP Pty Ltd	Compositions for treating respiratory tract infection and uses thereof
US12492223B2 (en) *	2021-07-23	2025-12-09	Lateral IP Pty Ltd	Peptide compositions capable of binding lanthionine synthetase C-like protein (LanCl) and uses thereof
CN117813105A (en) *	2021-07-23	2024-04-02	横向知识产权私人有限公司	Peptide compositions capable of binding to lanthionine synthetase C-like protein (LANCL) and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5378686A (en) *	1992-09-21	1995-01-03	Research Corporation Technologies, Inc.	Therapeutic treatment of fibromyalgia
CA2303395C (en) *	1997-09-08	2008-12-02	Metabolic Pharmaceuticals Ltd	Treatment of obesity
US20040077543A1 (en) *	2001-03-28	2004-04-22	Sah Dinah W. Y.	Treatment using neublastin polypeptides
CA2442159C (en) *	2001-03-28	2011-08-23	Biogen, Inc.	Treatment using neublastin polypeptides
EP1501539A1 (en) *	2002-05-03	2005-02-02	Metabolic Pharmaceuticals Ltd.	Method for control of depression using c terminal growth hormone (gh) fragment
WO2008131508A1 (en) *	2007-05-01	2008-11-06	Fundação De Amparo À Pesquisa Do Estado De São Paulo - Fapesp	Analgesic compounds
EP2788014B8 (en)	2011-12-09	2019-10-23	Metabolic Pharmaceuticals Pty Ltd	Use of growth hormone fragments
US10155026B2 (en) *	2015-12-03	2018-12-18	Children's Hospital Medical Center	Methods for treating pain caused by inflammation induced mechanical and/or thermal hypersensitivity

2019
- 2019-01-15 BR BR112020014330-8A patent/BR112020014330A2/en not_active Application Discontinuation
- 2019-01-15 AU AU2019207531A patent/AU2019207531B2/en not_active Ceased
- 2019-01-15 SG SG11202006669RA patent/SG11202006669RA/en unknown
- 2019-01-15 KR KR1020207023607A patent/KR20200130681A/en not_active Withdrawn
- 2019-01-15 RU RU2020123165A patent/RU2020123165A/en unknown
- 2019-01-15 JP JP2020558657A patent/JP7282099B2/en active Active
- 2019-01-15 CN CN201980017785.4A patent/CN112218650A/en active Pending
- 2019-01-15 WO PCT/AU2019/050020 patent/WO2019136528A1/en not_active Ceased
- 2019-01-15 CA CA3088014A patent/CA3088014A1/en active Pending
- 2019-01-15 US US16/962,082 patent/US20200390850A1/en not_active Abandoned
- 2019-01-15 EP EP19738271.6A patent/EP3740228A4/en not_active Ceased

Also Published As

Publication number	Publication date
US20200390850A1 (en)	2020-12-17
AU2019207531A1 (en)	2020-07-30
JP7282099B2 (en)	2023-05-26
JP2021510731A (en)	2021-04-30
KR20200130681A (en)	2020-11-19
CA3088014A1 (en)	2019-07-18
RU2020123165A (en)	2022-02-17
AU2019207531B2 (en)	2022-06-02
WO2019136528A1 (en)	2019-07-18
CN112218650A (en)	2021-01-12
EP3740228A1 (en)	2020-11-25
EP3740228A4 (en)	2021-12-15
BR112020014330A2 (en)	2020-12-08

Publication	Publication Date	Title
PL3615565T3 (en)	2025-08-18	Tcr and peptides
IL287781A (en)	2022-01-01	Clec12a-binding polypeptides and uses thereof
IL280808A (en)	2021-04-29	Ox40-binding polypeptides and uses thereof
GB201817821D0 (en)	2018-12-19	TCR and peptides
SG11202006669RA (en)	2020-08-28	Peptides and uses thereof
IL290414A (en)	2022-04-01	Atf5 peptide variants and uses thereof
GB2603645B (en)	2023-03-01	Polypeptides having anti-senescent effects and uses thereof
IL287782A (en)	2022-01-01	Cd33-binding polypeptides and uses thereof
EP3882263A4 (en)	2022-08-31	Glucagon-derived peptide and use thereof
GB201819200D0 (en)	2019-01-09	Polypeptide and uses thereof
IL287503A (en)	2021-12-01	Thiosemicarbazates and uses thereof
ZA201904386B (en)	2023-01-25	S-arrestin peptides and therapeutic uses thereof
EP3947418C0 (en)	2024-04-03	Peptides and use thereof
SG11202007887VA (en)	2020-09-29	Cyclic peptides and uses thereof
SG11202101090RA (en)	2021-03-30	Cdca1-derived peptide and vaccine containing same
HUP1700012A2 (en)	2018-07-30	Novel proteins and use thereof
PT3438118T (en)	2023-06-07	Peptide derivative and use thereof
IL280369A (en)	2021-03-01	New myokines and uses thereof
EP3325499A4 (en)	2018-12-26	Novel peptide and use thereof
IL284666A (en)	2021-08-31	Novel peptides and uses thereof
HK40041704A (en)	2021-08-20	Peptides and uses thereof
GB201812328D0 (en)	2018-09-12	Polypeptides and uses thereof
GB201817486D0 (en)	2018-12-12	Peptides and conjugates
AU2018900117A0 (en)	2018-01-25	Peptides and uses thereof
GB201818663D0 (en)	2019-01-02	Peptides and method